The effect of pioglitazone and extended-release niacin on HDL-cholesterol in diabetes patients in a real-world setting.
OBJECTIVE: This retrospective study was designed to assess the effects of the combination of pioglitazone and extended-release niacin on the lipid panel, particularly HDL-cholesterol, when used in patients with type 2 diabetes in an endocrinology specialt.....